Tani Mariko, Horvath Katalin V, Lamarche Benoit, Couture Patrick, Burnett John R, Schaefer Ernst J, Asztalos Bela F
Cardiovascular Nutrition Laboratory, Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA.
Institute on Nutraceuticals and Functional Foods, Laval University, Québec, Canada.
Atherosclerosis. 2016 Oct;253:7-14. doi: 10.1016/j.atherosclerosis.2016.08.014. Epub 2016 Aug 20.
Our aim was to gain insight into the role that lipoprotein lipase (LPL) and hepatic lipase (HL) plays in HDL metabolism and to better understand LPL- and HL-deficiency states.
We examined the apolipoprotein (apo) A-I-, A-II-, A-IV-, C-I-, C-III-, and E-containing HDL subpopulation profiles, assessed by native 2-dimensional gel-electrophoresis and immunoblotting, in 6 homozygous and 11 heterozygous LPL-deficient, 6 homozygous and 4 heterozygous HL-deficient, and 50 control subjects.
LPL-deficient homozygotes had marked hypertriglyceridemia and significant decreases in LDL-C, HDL-C, and apoA-I. Their apoA-I-containing HDL subpopulation profile was shifted toward small HDL particles compared to controls. HL-deficient homozygotes had moderate hypertriglyceridemia, modest increases in LDL-C and HDL-C level, but normal apoA-I concentration. HL-deficient homozygotes had a unique distribution of apoA-I-containing HDL particles. The normally apoA-I:A-II, intermediate-size (α-2 and α-3) particles were significantly decreased, while the normally apoA-I only (very large α-1, small α-4, and very small preβ-1) particles were significantly elevated. In contrast to control subjects, the very large α-1 particles of HL-deficient homozygotes were enriched in apoA-II. Homozygous LPL- and HL-deficient subjects also had abnormal distributions of apo C-I, C-III, and E in HDL particles. Values for all measured parameters in LPL- and HL-deficient heterozygotes were closer to values measured in controls than in homozygotes.
Our data are consistent with the concept that LPL is important for the maturation of small discoidal HDL particles into large spherical HDL particles, while HL is important for HDL remodeling of very large HDL particles into intermediate-size HDL particles.
我们的目的是深入了解脂蛋白脂肪酶(LPL)和肝脂肪酶(HL)在高密度脂蛋白(HDL)代谢中的作用,并更好地理解LPL和HL缺乏状态。
我们通过天然二维凝胶电泳和免疫印迹法,检测了6名纯合子和11名杂合子LPL缺乏者、6名纯合子和4名杂合子HL缺乏者以及50名对照者中含载脂蛋白(apo)A-I、A-II、A-IV、C-I、C-III和E的HDL亚群谱。
LPL缺乏的纯合子有明显的高甘油三酯血症,低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)和apoA-I显著降低。与对照组相比,他们含apoA-I的HDL亚群谱向小HDL颗粒偏移。HL缺乏的纯合子有中度高甘油三酯血症,LDL-C和HDL-C水平适度升高,但apoA-I浓度正常。HL缺乏的纯合子含apoA-I的HDL颗粒有独特的分布。正常的apoA-I:A-II中等大小(α-2和α-3)颗粒显著减少,而正常的仅含apoA-I(非常大的α-1、小的α-4和非常小的前β-1)颗粒显著升高。与对照者相比,HL缺乏纯合子的非常大的α-1颗粒富含apoA-II。纯合子LPL和HL缺乏者HDL颗粒中apo C-I、C-III和E的分布也异常。LPL和HL缺乏杂合子所有测量参数的值比纯合子更接近对照组测量的值。
我们的数据与以下概念一致,即LPL对小圆盘状HDL颗粒成熟为大球状HDL颗粒很重要,而HL对非常大的HDL颗粒重塑为中等大小的HDL颗粒很重要。